Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Eli Lilly and Co LLY

Healthcare
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:LLY)

6 Stocks Positioned to Soar as Investors Focus on MASH

TheNewsWire 3 days ago

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity

PR Newswire 8 days ago

Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement

PR Newswire 9 days ago

More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study

PR Newswire March 10, 2024

U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab

PR Newswire March 8, 2024

Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care

PR Newswire March 7, 2024

Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting

PR Newswire March 5, 2024

Lilly to Participate in Cowen's 44th Annual Health Care Conference

PR Newswire February 20, 2024

Philip Johnson to Retire as Lilly Treasurer

PR Newswire February 9, 2024
View More News ››

Opinion & Analysis (NYSE:LLY)

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results

Streetwise Reports June 17, 2020

Possible 'best-in-class' alzheimer's drug candidate offers 'disruptive' potential

The Life Sciences Report September 21, 2017

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017

Diffusion Pharmaceuticals takes aim at brain cancer: CEO David Kalergis

The Life Sciences Report April 1, 2016

The next leg of the health care boom is under way

Dr. David Eifrig June 15, 2015

Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary

Benzinga.com  July 30, 2014
View More Opinion ››

Bullboard Posts (NYSE:LLY)

Watching

For healthcare rotation. Looking to enter on pullback.
jboom70 - February 8, 2024

actually rising

been watching since 2010
satchmo6 - February 5, 2024

stock has been faring very well on the stock market

currently forming a flat base with an ideal buy point of 335.43, according to MarketSmith analysis.   Shares are currently...
jw1trader - September 28, 2022

RE:Putin said he will squash this company

DOWN  2 bucks----its starting------
satchmo6 - September 17, 2021

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Does Emergency Use override safety?

https://www.channelchek.com/news-channel/The_Timing_of_a_COVID_Vaccine
SmallCapPaul - October 7, 2020
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »